drugset / Trial / NCT04224831

Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma

NCT04224831

Completed 22 enrolled Ankara University Technopolis
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Purpose: To investigate the efficacy of combined use of retinal repetitive electromagnetic stimulation and subtenon autologous platelet-rich plasma in the treatment of recalcitrant or unresponsive chronic central serous chorioretinopathy.

Timeline

Start
2018-12-01
Primary completion
2019-09-30
Completion
2020-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other